Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: TRANSPLANTATION, HOMOLOGOUS - ADVERSE EFFECTS, . Treffer: 13
2016
Hartz, B; Marsh, R; Rao, K; Henter, JI; Jordan, M; Filipovich, L; Bader, P; Beier, R; Burkhardt, B; Meisel, R; Schulz, A; Winkler, B; Albert, MH; Greil, J; Karasu, G; Woessmann, W; Corbacioglu, S; Gruhn, B; Holter, W; Kühl, JS; Lang, P; Seidel, MG; Veys, P; Löfstedt, A; Ammann, S; Ehl, S; Janka, G; Müller, I; Lehmberg, K
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis.
Blood. 2016; 127(25):3281-3290
Doi: 10.1182/blood-2015-12-684498
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pearce, KF; Balavarca, Y; Norden, J; Jackson, G; Holler, E; Dressel, R; Greinix, H; Toubert, A; Gluckman, E; Hromadnikova, I; Sedlacek, P; Wolff, D; Holtick, U; Bickeböller, H; Dickinson, AM
Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia.
Int J Immunogenet. 2016; 43(6):404-412
Doi: 10.1111/iji.12295
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Harrison, N; Mitterbauer, M; Tobudic, S; Kalhs, P; Rabitsch, W; Greinix, H; Burgmann, H; Willinger, B; Presterl, E; Forstner, C
Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
BMC Infect Dis. 2015; 15(7):584-584
Doi: 10.1186/s12879-015-1329-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Busemann, C; Ribback, S; Zimmermann, K; Sailer, V; Kiefer, T; Schmidt, CA; Schulz, K; Steinmetz, I; Dombrowski, F; Dölken, G; Krüger, WH
Toxoplasmosis after allogeneic stem cell transplantation--a single centre experience.
Ann Hematol. 2012; 91(7):1081-1089
Doi: 10.1007/s00277-012-1406-5
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2008
Hildebrandt, GC; Granell, M; Urbano-Ispizua, A; Wolff, D; Hertenstein, B; Greinix, HT; Brenmoehl, J; Schulz, C; Dickinson, AM; Hahn, J; Rogler, G; Andreesen, R; Holler, E
Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.
Biol Blood Marrow Transplant. 2008; 14(1): 67-74.
Doi: 10.1016/j.bbmt.2007.09.009
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Uderzo, C; Pillon, M; Corti, P; Tridello, G; Tana, F; Zintl, F; Nysom, K; Galambrun, C; Fagioli, F; Varotto, S; Messina, C; Verdeguer, A; Urban, C; Faraci, M; Dini, G; Fedeli, S; Tichelli, A; Rovelli, A; Socié, G
Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
Bone Marrow Transplant. 2007; 39(11): 667-675.
Doi: 10.1038/sj.bmt.1705652
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2006
Felder-Puig, R; di Gallo, A; Waldenmair, M; Norden, P; Winter, A; Gadner, H; Topf, R
Health-related quality of life of pediatric patients receiving allogeneic stem cell or bone marrow transplantation: results of a longitudinal, multi-center study.
Bone Marrow Transplant. 2006; 38(2):119-126
Doi: 10.1038/sj.bmt.1705417
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2003
Benesch, M; McDonald, GB; Schubert, M; Appelbaum, FR; Deeg, HJ
Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study.
BONE MARROW TRANSPLANT. 2003; 32(11): 1071-1075.
Doi: 10.1038/sj.bmt.1704277
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Peniket, AJ; Ruiz de Elvira, MC; Taghipour, G; Cordonnier, C; Gluckman, E; de Witte, T; Santini, G; Blaise, D; Greinix, H; Ferrant, A; Cornelissen, J; Schmitz, N; Goldstone, AH; European Bone Marrow Transplantation (EBMT) Lymphoma Registry
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Bone Marrow Transplant. 2003; 31(8):667-678
Doi: 10.1038/sj.bmt.1703891
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2002
Urban, CH; Deutschmann, A; Kerbl, R; Lackner, H; Schwinger, W; Königsrainer, A; Margreiter, R
Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Bone Marrow Transplant. 2002; 30(8):535-537
Doi: 10.1038/sj.bmt.1703688
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Worel, N; Greinix, HT; Keil, F; Mitterbauer, M; Lechner, K; Fischer, G; Mayr, W; Höcker, P; Kalhs, P
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
Transfusion. 2002; 42(10):1293-1301
Doi: 10.1046/j.1537-2995.2002.00209.x
Web of Science
PubMed
FullText
FullText_MUG
1997
Gerber, M; Gmeinhart, B; Volc-Platzer, B; Kalhs, P; Greinix, H; Knobler, R
Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
Bone Marrow Transplant. 1997; 19(5):517-519
Doi: 10.1038/sj.bmt.1700661
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1994
Link, H; Boogaerts, MA; Fauser, AA; Slavin, S; Reiffers, J; Gorin, NC; Carella, AM; Mandelli, F; Burdach, S; Ferrant, A; Linkesch, W; Tura S; Bacigalupo A, Schindel, F; Heinrichs, H
A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
BLOOD. 1994; 84(10): 3327-3335.
Doi: 10.1182/blood.V84.10.3327.bloodjournal84103327
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG